Guideline document
This guideline is provided for in-page reading only. Please contact the publishing organization for downloadable copies.
Neuroblastoma PDQ®
Topic overview
Comprehensive NCI clinical reference for healthcare professionals managing neuroblastoma, the most common extracranial solid tumor in children. Covers evidence-based treatment protocols including risk-based stratification, multimodal therapy approaches with surgery, chemotherapy, radiation, and immunotherapy, plus prognostic factors and current clinical trial information.
Key Takeaways
- Neuroblastoma is the most common extracranial solid tumor in children, often presenting with abdominal mass or metastatic disease.
- Risk stratification uses age, stage, MYCN amplification, and histology to guide treatment intensity from observation to multimodal therapy.
- High-risk disease requires intensive chemotherapy, surgery, radiation, stem cell transplant, and immunotherapy for optimal outcomes.
- Infants with localized disease may have spontaneous regression; observation alone is appropriate for select low-risk patients.
- Long-term surveillance is essential due to risks of recurrence, secondary malignancies, and treatment-related late effects.
Keywords
Hashtags
Full guideline text
Full text not available for this guideline
How to cite: GlobalCastMD. Neuroblastoma PDQ®. GlobalCastMD Medical Library. https://library.globalcastmd.com/guideline/2381
Comments